- Radboud Repository
- →
- Browsing by Author
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing by Author "Oort, I.M. van"
Now showing items 1-50 of 76
-
-
Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naive Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study Leest, M.M. van der; Cornel, Erik; ; Hendriks, R.J.; Padhani, Anwar R.; Hoogenboom, M.; Zamecnik, P.; ; Sedelaar, M.; ; et al.2019, Article / Letter to editor (European Urology, vol. 75, iss. 4, (2019), pp. 570-578)
sine al.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relation Badrising, S.K.; Noort, V van; Eertwegh, A.J. van den; Hamberg, P.; ; Berg, H.P. van den; Los, M.; Aarts, M.J.; Coenen, J.L.; Gelderblom, H.; et al.2016, Article / Letter to editor (Prostate, vol. 76, iss. 1, (2016), pp. 32-40)
sine al.
-
-
-
-
Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer Badrising, S.K.; Noort, V van; Hamberg, P.; Coenen, J.L.; Aarts, M.J.; ; Eertwegh, A.J. van den; Los, M.; Berg, H.P. van den; Gelderblom, H.; et al.2016, Article / Letter to editor (Oncology (Basel: 1948), vol. 91, iss. 5, (2016), pp. 267-273)
sine al.
-
-
Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score. Neste, L. Van; Hendriks, R.J.; ; Trooskens, G.; Cornel, E.B.; Jannink, S.A.; Jong, H. de; Hessels, D.; Smit, F.P.; ; et al.2016, Article / Letter to editor (European Urology, vol. 70, iss. 5, (2016), pp. 740-748)
sine al.
-
-
-
Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based survey. Surcel, C.I.; Sooriakumaran, P.; Briganti, A.; Visschere, P.J. De; ; Ghadjar, P.; Isbarn, H.; Ost, P.; Ploussard, G.; Bergh, R.C. van den; et al.2015, Article / Letter to editor (Bju International, vol. 115, iss. 4, (2015), pp. 571-579)
sine al.
-
Prognostic effect of neuroendocrine differentiation in prostate cancer: A critical review Surcel, C.I.; ; Sooriakumaran, P.; Briganti, A.; Visschere, P.J. De; ; Ghadjar, P.; Isbarn, H.; Ost, P.; Bergh, R.C. van den; et al.2015, Article / Letter to editor (Urologic Oncology-Seminars and Original Investigations, vol. 33, iss. 6, (2015), pp. 265.e1-265.e7)
sine al.
-
Systematic ultrasound-guided saturation and template biopsy of the prostate: Indications and advantages of extended sampling Isbarn, H.; Briganti, B.; Visschere, P.J. De; ; Ghadjar, P.; Giannarini, G.; Ost, P.; Ploussard, G.; Sooriakumaran, P.; Surcel, C.; et al.2015, Article / Letter to editor (Archivos Espanõles de Urología, vol. 68, iss. 3, (2015), pp. 296-306)
sine al.
-
The oncologic role of local treatment in primary metastatic prostate cancer Ghadjar, P.; Briganti, A.; Visschere, P.J. De; ; Giannarini, G.; Isbarn, H.; Ost, P.; Sooriakumaran, P.; Surcel, C.I.; Bergh, R.C. van den; et al.2015, Article / Letter to editor (World Journal of Urology, vol. 33, iss. 6, (2015), pp. 755-761)
sine al.
-
Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients Ploussard, G.; Isbarn, H.; Briganti, A.; Sooriakumaran, P.; Surcel, C.I.; Salomon, L.; Freschi, M.; Mirvald, C.; Poel, H.G. van der; Jenkins, A.; et al.2015, Article / Letter to editor (Urologic Oncology-Seminars and Original Investigations, vol. 33, iss. 2, (2015), pp. 71.e1-9)
sine al.
-
CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel Wissing, M.D.; Coenen, J.L.; Berg, P. van den; Westgeest, H.M.; Eertwegh, A.J. van den; ; Bos, M.M.; Bergman, A.M.; Hamberg, P.; Tije, A.J. Ten; et al.2015, Article / Letter to editor (International Journal of Cancer, vol. 136, iss. 6, (2015), pp. E760-72)
sine al.
-
-
Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial Saad, F.; Fizazi, K.; Jinga, V.; Efstathiou, E.; Fong, P.C.; Hart, L.L.; Jones, R.; McDermott, R.; Wirth, M.; Suzuki, K.; et al.2015, Article / Letter to editor (Lancet Oncology, vol. 16, iss. 3, (2015), pp. 338-348)
sine al.
-
Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer Leyten, G.H.J.M.; Hessels, D.; Smit, F.P.; Jannink, S.A.; Jong, H. de; ; Cornel, E.B.; Reijke, T.M. de; Vergunst, H.; Kil, P.; et al.2015, Article / Letter to editor (Clinical Cancer Research, vol. 21, iss. 13, (2015), pp. 3061-3070)
sine al.
-
Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer Leyten, G.H.J.M.; ; ; ; ; ; Reijke, T.M. de; Vergunst, H.; Kil, P.; ; et al.2014, Article / Letter to editor (European Urology, vol. 65, iss. 3, (2014), pp. 534-542)
sine al.
-
Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study ; Somford, D.M.; ; Vergunst, H.; Oddens, J.R.; ; Roobol, M.J.; Bul, M.; ; ; et al.2014, Article / Letter to editor (Investigative Radiology, vol. 49, iss. 3, (2014), pp. 165-172)
sine al.
-
Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment Badrising, S.; Noort, V van; ; Berg, H.P. van den; Los, M.; Hamberg, P.; Coenen, J.L.; Eertwegh, A.J. van den; Jong, I.J. de; Kerver, E.D.; et al.2014, Article / Letter to editor (Cancer, vol. 120, iss. 7, (2014), pp. 968-975)
sine al.
-
-
Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: results of the European compassionate-use programme Heidenreich, A.; Bracarda, S.; Mason, M.; Ozen, H.; Sengelov, L.; ; Papandreou, C.; Fossa, S.; Hitier, S.; Climent, M.A.; et al.2014, Article / Letter to editor (European Journal of Cancer, vol. 50, iss. 6, (2014), pp. 1090-1099)
sine al.
-
-
-
-
-
The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer Somford, D.M.; Hamoen, E.H.J.; ; Basten, J.P. van; ; Vreuls, W.; ; Vergunst, H.; ; ; et al.2013, Article / Letter to editor (Journal of Urology, vol. 190, iss. 5, (2013), pp. 1728-1734)
sine al.
-
Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer Somford, D.M.; ; ; ; ; ; Bangma, C.H.; Vergunst, H.; ; Oddens, J.R.; et al.2013, Article / Letter to editor (Investigative Radiology, vol. 48, iss. 3, (2013), pp. 152-157)
sine al.
-
-
-
-
-
-
Value of PET/CT and MR lymphography in treatment of prostate cancer patients with lymph node metastases Fortuin, A.S.; ; ; ; ; ; Reske, S.N.; Schick, C.; Krause, B.J.; ; et al.2012, Article / Letter to editor (International Journal of Radiation Oncology, Biology, Physics, vol. 84, iss. 3, (2012), pp. 712-718)
sine al.
Now showing items 1-50 of 76
Upload Full Text